Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-07-01

Clinical Trial Update: Low Dose Aspirin for the Prevention of Preeclampsia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating low-dose aspirin for preventing preeclampsia is ongoing, with no current status reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (low-dose) (acetylsalicylic acid)

Snippet

Sponsor: Saint Thomas Hospital, Panama | Conditions: Preeclampsia | Phase 3 | Status: UNKNOWN